Low-dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in...
Peginterferon Alfa-2A (Pegasys) – Apotheker-Bewertung – Anwendung, Dosierung, Nebenwirkungen
Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
Comparing Hydroxyurea and Pegylated Interferon-Alpha-2a in PV and ET
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic...
The treatment schedule for interferon therapy in patients with PV
Evaluating Ruxolitinib With Pegylated Interferon Alfa-2a in Myelofibrosis
Ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
The recent shortage of peginterferon alfa-2a and the role of this agent in MPNs
MPD-RC 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
Combo of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of HBsAG in Hepatitis B
Injection Tips Pegasys Interferon peginterferon alfa-2a for the Treatment of Polycythemia Vera MPN
What can be learnt about using interferon in patients with myelofibrosis?
Failed Pegasys Interferon Alfa 2a - telehealth - polycythemia vera MPN Myeloproliferative Neoplasm
Long-term Phase II results of pegylated interferon treatment in ET and PV
Risk-adapted treatment of ET & PV
Peginterferon & Ribavirin
A Genetic Screen Identifies Interferon Alfa Effector Genes Required to Suppress Hepatitis C...
Dr. Kambhampati on Ropeginterferon Alfa-2b in Myeloproliferative Neoplasms
Pegylated Interferon Alpha – Supply & Commissioning Update